# L-cysteine Prevents Stomach Exposure to Carcinogenic Acetaldehyde

> **NCT02524262** · PHASE2 · COMPLETED · sponsor: **Per Hellström** · enrollment: 8 (actual)

## Conditions studied

- Gastritis, Atrophic

## Interventions

- **DIETARY_SUPPLEMENT:** Slow-release L-cysteine

## Key facts

- **NCT ID:** NCT02524262
- **Lead sponsor:** Per Hellström
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2016-01-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02524262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02524262, "L-cysteine Prevents Stomach Exposure to Carcinogenic Acetaldehyde". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02524262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*